Dhampur Bio Organics Limited carries a market capitalization of 7.44B, placing it among publicly traded companies globally. Its enterprise value stands at 17.92B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.44B |
| Enterprise Value | 17.92B |
Dhampur Bio Organics Limited currently has 65.79M shares outstanding.
| Shares Outstanding | 65.79M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Dhampur Bio Organics Limited trades at a trailing price-to-earnings ratio of 30.53. The price-to-sales ratio is 0.36, and the price-to-book ratio stands at 11.58.
| PE Ratio | 30.53 |
| PS Ratio | 0.36 |
| PB Ratio | 11.58 |
| P/TBV Ratio | 0.75 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Dhampur Bio Organics Limited trades at an EV/EBITDA multiple of 24.87 and an EV/FCF ratio of 46.22. The EV/Sales ratio of 0.85 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 24.87 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.85 |
| EV / EBITDA | 24.87 |
| EV / EBIT | 24.87 |
| EV / FCF | 46.22 |
Dhampur Bio Organics Limited maintains a current ratio of 1.16, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 103.29, indicating elevated leverage, while an interest coverage ratio of 1.14 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.16 |
| Quick Ratio | 0.04 |
| Debt / Equity | 103.29 |
| Debt / EBITDA | 14.72 |
| Interest Coverage | 1.14 |
Dhampur Bio Organics Limited posts a return on equity of 13.71 and a return on invested capital of 2.08.
| Return on Equity (ROE) | 13.71 |
| Return on Assets (ROA) | 1.07 |
| Return on Invested Capital (ROIC) | 2.08 |
| Return on Capital Employed (ROCE) | 4.94 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.52 |
Over the trailing twelve months, Dhampur Bio Organics Limited has paid 157.20M in income taxes, reflecting an effective tax rate of 38.44.
| Income Tax | 157.20M |
| Effective Tax Rate | 38.44 |
Dhampur Bio Organics Limited's stock has gained approximately 34.9642% over the past 52 weeks. The 50-day moving average sits at 112.99, while the 200-day moving average is 95.15.
| Beta (5Y) | N/A |
| 52-Week Price Change | 34.9642% |
| 50-Day Moving Average | 112.99 |
| 200-Day Moving Average | 95.15 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Dhampur Bio Organics Limited generated 21.09B in revenue and converted that into 251.80M in net income, yielding earnings per share of 3.80. EBITDA reached 720.50M, while operating income came in at 720.50M.
| Revenue | 21.09B |
| Gross Profit | 5.11B |
| Operating Income | 720.50M |
| Pretax Income | 409.00M |
| Net Income | 251.80M |
| EBITDA | 720.50M |
| EBIT | 720.50M |
| Earnings Per Share (EPS) | 3.80 |
Dhampur Bio Organics Limited holds 371.80M in cash and equivalents against 10.60B in total debt, resulting in a net debt position of 10.45B. Total book value stands at 663.90M, with working capital of 1.67B providing operational flexibility.
| Cash & Cash Equivalents | 371.80M |
| Total Debt | 10.60B |
| Net Debt | 10.45B |
| Equity (Book Value) | 663.90M |
| Book Value Per Share | 10.03 |
| Working Capital | 1.67B |
Dhampur Bio Organics Limited operates with a gross margin of 24.22, reflecting its pricing power and cost economics. The operating margin of 3.42 and net profit margin of 1.19 provide insight into operational efficiency.
| Gross Margin | 24.22 |
| Operating Margin | 3.42 |
| Pretax Margin | 1.94 |
| Profit Margin | 1.19 |
| EBITDA Margin | 3.42 |
Dhampur Bio Organics Limited posts an Altman Z-Score of 1.45, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.45 |